Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude

Código QR

Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude

Yu Cao,1,* Gongfeng Li,1,* Jinsheng Xue,2,* Guijuan Zhang,1 Sensen Gao,1 Yuling Huang,1 Aiqin Zhu1 1Institute of Geriatric, Qinghai Provincial People’s Hospital, Xining, People’s Republic of China; 2Foreign Cooperation Office, Chengdu Fifth People’s Hospital, Chengdu, P...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cao Y, Li G, Xue J, Zhang G, Gao S, Huang Y, Zhu A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	high altitude parkinson’s disease depression motor symptoms non-motor symptoms Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/99d14fe6be3243cfb7e47c8ae6aee224
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
por: Berardelli I, et al.
Publicado: (2018)

The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease
por: Ting-Chun Fang, et al.
Publicado: (2021)

Different Associated Factors of Subjective Cognitive Complaints in Patients With Early- and Late-Onset Parkinson's Disease
por: Yi Xiao, et al.
Publicado: (2021)

Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol
por: Kristina J. Pfeifer, et al.
Publicado: (2021)

Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson’s Disease Patients: A Cross-Sectional Study in a Single Center
por: Ren J, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021)

Gut microbiota in Parkinson’s disease patients: hospital-based study
por: Eman M. Khedr, et al.
Publicado: (2021)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Characteristics of Autonomic Dysfunction in Parkinson’s Disease: A Large Chinese Multicenter Cohort Study
por: Zhou Zhou, et al.
Publicado: (2021)

Symptom dimensions of anxiety in Parkinson’s disease: Replication study in a neuropsychiatric patient population
por: Sonja Rutten, et al.
Publicado: (2021)

Effect of Acupuncture on Movement Function in Patients with Parkinson’s Disease: Network Meta-Analysis of Randomized Controlled Trials
por: Miri Kwon, et al.
Publicado: (2021)

Cytokines and depression in cancer patients and caregivers
por: Li M, et al.
Publicado: (2017)

Galvanic Vestibular Stimulation Effects on EEG Biomarkers of Motor Vigor in Parkinson's Disease
por: Alireza Kazemi, et al.
Publicado: (2021)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Chenxi Pan, et al.
Publicado: (2021)

Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage
por: Emma M. Devenney, et al.
Publicado: (2021)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami H, et al.
Publicado: (2017)

Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer’s disease
por: Zhang J, et al.
Publicado: (2017)

Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
por: Harada E, et al.
Publicado: (2016)

Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode
por: Yoshizawa K, et al.
Publicado: (2021)

Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: a meta-analysis of randomized, controlled clinical trials
por: Qin B, et al.
Publicado: (2018)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
por: Werner Poewe, et al.
Publicado: (2010)

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
por: Szász JA, et al.
Publicado: (2019)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: José-Francisco Rocha, et al.
Publicado: (2021)

Subthreshold Depression Needs A Prime Time In Old Age Psychiatry? A Narrative Review Of Current Evidence
por: Biella MM, et al.
Publicado: (2019)

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment
por: Kasemsap N, et al.
Publicado: (2016)

Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
por: Harada E, et al.
Publicado: (2017)

Estudio del Efecto de la Altitud sobre el Comportamiento de Motores de Combustión Interna. Parte 1: Funcionamiento
por: Lapuerta,Magín, et al.
Publicado: (2006)

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata R, et al.
Publicado: (2016)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino C, et al.
Publicado: (2016)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

Correlations Between SIRT Genetic Polymorphisms and Postpartum Depressive Symptoms in Chinese Parturients Who Had Undergone Cesarean Section
por: Luo SC, et al.
Publicado: (2020)

Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study
por: Shinmei I, et al.
Publicado: (2016)

The impact of residual symptoms on relapse and quality of life among Thai depressive patients
por: Hiranyatheb T, et al.
Publicado: (2016)

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
por: Saragoussi D, et al.
Publicado: (2018)

Combined Effects of Mother’s, Father’s and Teacher’s Psychological Distress on Schoolchildren’s Mental Health Symptoms
por: Li S, et al.
Publicado: (2021)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
por: Zhang H, et al.
Publicado: (2019)

Personality associated with depressive status in individuals with type 2 diabetes mellitus
por: Yasui-Furukori N, et al.
Publicado: (2019)

Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report
por: Takagaki K, et al.
Publicado: (2018)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs BL, et al.
Publicado: (2017)

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
por: Correia-Melo FS, et al.
Publicado: (2017)